Skip to main content
. 2005 Dec;103:46–55.

TABLE 3.

SUBGROUP ANALYSIS FOR GLAUCOMA DEVELOPMENT: IOL IMPLANTATION VERSUS TIMING OF SURGERY IN EYES THAT DEVELOPED GLAUCOMA

SUBGROUP TREATMENT VARIABLES GLAUCOMA INCIDENCE
1 IOL and age ≥30 days 0/49 (0%)
2* No IOL and age ≥30 days 4/44 (9.1%)
3* No IOL and age <30 days 9/23 (39.1%)

IOL = intraocular lens.

The pairwise comparison between subgroups 2 and 3 was statistically significant (P value of the chi-square: .016).